申请人:OTSUKA PHARMA CO LTD
公开号:WO2017212329A1
公开(公告)日:2017-12-14
This invention relates to proteolysis targeting chimeric molecules formed from the intracellular self-assembly of precursors via bioorthogonal click chemistry (CLIPTACs), as well as related precursor compositions, methods and therapeutic applications.
这项发明涉及通过生物正交点击化学(CLIPTACs)形成的前体的细胞内自组装的蛋白水解靶向嵌合分子,以及相关的前体组合物、方法和治疗应用。